Avicanna Inc. (AVCN.TO)

CAD 0.34

(1.49%)

Revenue Summary of Avicanna Inc.

Avicanna Inc.'s latest annual revenue in 2023 was 16.79 Million CAD , up 314.82% from previous year.
Avicanna Inc.'s latest quarterly revenue in 2024 Q1 was 6.44 Million CAD , up 6.48% from previous quarter.
Avicanna Inc. reported a annual revenue of 4.04 Million CAD in annual revenue 2022, up 23.83% from previous year.
Avicanna Inc. reported a annual revenue of 3.26 Million CAD in annual revenue 2021, up 108.2% from previous year.
Avicanna Inc. reported a quarterly revenue of 6.12 Million CAD for 2024 Q2, down -5.01% from previous quarter.
Avicanna Inc. reported a quarterly revenue of 6.05 Million CAD for 2023 Q4, down -3.19% from previous quarter.

Annual Revenue Chart of Avicanna Inc. (2023 - 2016)

Historical Annual Revenue of Avicanna Inc. (2023 - 2016)

Year	Revenue	Revenue Growth
2023	16.79 Million CAD	314.82%
2022	4.04 Million CAD	23.83%
2021	3.26 Million CAD	108.2%
2020	1.57 Million CAD	833.16%
2019	168.25 Thousand CAD	42.62%
2018	117.97 Thousand CAD	342.49%
2017	26.66 Thousand CAD	0.0%
2016	- CAD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	6.44 Million CAD	6.48%
2024 Q2	6.12 Million CAD	-5.01%
2023 Q4	6.05 Million CAD	-3.19%
2023 FY	16.79 Million CAD	314.82%
2023 Q3	6.25 Million CAD	88.63%
2023 Q2	3.31 Million CAD	183.27%
2023 Q1	1.17 Million CAD	3.0%
2022 Q1	1.03 Million CAD	-14.77%
2022 FY	4.04 Million CAD	23.83%
2022 Q4	1.13 Million CAD	47.3%
2022 Q3	771.26 Thousand CAD	-30.05%
2022 Q2	1.1 Million CAD	6.22%
2021 Q2	792.22 Thousand CAD	192.43%
2021 FY	3.26 Million CAD	108.2%
2021 Q1	270.9 Thousand CAD	195.98%
2021 Q4	1.21 Million CAD	23.26%
2021 Q3	987.96 Thousand CAD	24.71%
2020 Q3	881.95 Thousand CAD	24.31%
2020 Q2	709.46 Thousand CAD	171.93%
2020 FY	1.57 Million CAD	833.16%
2020 Q1	260.9 Thousand CAD	112.61%
2020 Q4	-282.26 Thousand CAD	-132.0%
2019 Q4	122.71 Thousand CAD	2382.6%
2019 Q3	4943.00 CAD	-70.17%
2019 FY	168.25 Thousand CAD	42.62%
2019 Q2	16.57 Thousand CAD	-31.02%
2019 Q1	24.02 Thousand CAD	-0.49%
2018 Q2	25.15 Thousand CAD	-24.92%
2018 FY	117.97 Thousand CAD	342.49%
2018 Q4	24.14 Thousand CAD	-31.35%
2018 Q3	35.16 Thousand CAD	39.79%
2018 Q1	33.5 Thousand CAD	71.28%
2017 Q4	19.56 Thousand CAD	175.61%
2017 FY	26.66 Thousand CAD	0.0%
2017 Q3	7098.00 CAD	0.0%
2016 FY	- CAD	0.0%

Peer Revenue Comparison of Avicanna Inc.

Name	Revenue	Revenue Difference
Aurora Cannabis Inc.	270.28 Million CAD	93.787%
Avant Brands Inc.	26.34 Million CAD	36.261%
Cardiol Therapeutics Inc.	- CAD	-Infinity%
Crescita Therapeutics Inc.	17.52 Million CAD	4.169%
Knight Therapeutics Inc.	328.19 Million CAD	94.884%
MediPharm Labs Corp.	33.06 Million CAD	49.212%
OrganiGram Holdings Inc.	149.2 Million CAD	88.746%
Canopy Growth Corporation	297.14 Million CAD	94.349%
Willow Biosciences Inc.	1.17 Million CAD	-1332.72%
Auxly Cannabis Group Inc.	101.07 Million CAD	83.388%